Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$432/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

NanoSphere Health Sciences Inc. (C:NSHS)

Business Focus: Generic Pharmaceuticals

Sector:  Healthcare Industry:  Pharmaceuticals
 
Company Contact
Address: 8400 E Crescent Pkwy Ste 600
GREENWOOD VILLAGE CO 80111-2842
Tel: N/A
Website: https://www.nanospherehealth.com
IR: See website
Key People
N/A    
Business Overview
NanoSphere Health Sciences Inc. is a nano-biotechnology company. The Company is focused on providing delivery of biologically active compounds through licensing and joint venture arrangements. The Company has created a patented NanoSphere Deliver System, a platform using nanotechnology in the biodelivery of supplements, nutraceuticals and over-the-counter medications for the cannabis, pharmaceutical and animal health industries. Its wholly owned subsidiary is NanoSphere Health Sciences, LLC (NanoSphere LLC). NanoSphere LLC is the Company's operating division in the United States.
Financial Overview
For the nine months ended 30 September 2023, Nanosphere Health Sciences Inc revenues was not reported. Net loss decreased 8% to $173K. Lower net loss reflects Foreign Exchange Gain/LossNon-Business decrease from $21K (expense) to $0K, Labor & Related Expenses in SGA decrease of 8% to $68K (expense), Share-based payments decrease of 65% to $3K (expense). Basic Earnings per Share excluding Extraordinary Items remained flat at -$0.02.
Reporting Currency: U.S. Dollars
Enterprise value: $0.18M as of Sep 30, 2023
Annual revenue (TTM): $0.00M as of Sep 30, 2023
EBITDA (TTM): -$0.40M as of Sep 30, 2023
Net annual income (TTM): -$0.36M as of Sep 30, 2023
Free cash flow (TTM): -$0.04M as of Sep 30, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 10,275,205 as of Sep 30, 2023
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization